Effect of Compatibility of Wujiwan on Pharmacokinetics and Tissue Distribution of Representative Components

DONG Yu; CHEN Ying; GONG Zipeng; YANG Qing; WENG Xiaogang; WANG Yajie; ZHU Xiaoxin; ZHANG Chenhao

doi:10.13422/j.cnki.syfjx.20231169

您当前的位置：

首页 >

文章列表页 >

Effect of Compatibility of Wujiwan on Pharmacokinetics and Tissue Distribution of Representative Components

更新时间：2023-12-28

- Effect of Compatibility of Wujiwan on Pharmacokinetics and Tissue Distribution of Representative Components
  增强出版
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 3, Pages: 105-113(2024)
- 作者机构：
  
  1.中国中医科学院广安门医院，北京 100053
  2.中国中医科学院中药研究所，北京 100700
  3.贵州医科大学贵州省药物制剂重点实验室，贵阳 550004
  4.中国中医科学院望京医院，北京 100102
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20231169
  CLC： R22;R28;R969.1;O657
- Received：21 March 2023，
  
  Published Online：05 July 2023，
  
  Published：05 February 2024
- 稿件说明：
移动端阅览
董宇,陈颖,巩仔鹏等.戊己丸配伍对代表成分体内药代动力学和组织分布的影响[J].中国实验方剂学杂志,2024,30(03):105-113.

DONG Yu,CHEN Ying,GONG Zipeng,et al.Effect of Compatibility of Wujiwan on Pharmacokinetics and Tissue Distribution of Representative Components[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(03):105-113.
董宇,陈颖,巩仔鹏等.戊己丸配伍对代表成分体内药代动力学和组织分布的影响[J].中国实验方剂学杂志,2024,30(03):105-113. DOI： 10.13422/j.cnki.syfjx.20231169.

DONG Yu,CHEN Ying,GONG Zipeng,et al.Effect of Compatibility of Wujiwan on Pharmacokinetics and Tissue Distribution of Representative Components[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(03):105-113. DOI： 10.13422/j.cnki.syfjx.20231169.

摘要

目的

研究戊己丸中5个代表成分血浆药代动力学及组织分布的情况，从戊己丸在配伍前后体内代谢和组织分布的差异变化说明方剂配伍的特点。

方法

将260只健康雄性SD大鼠分为戊己丸组（62.96 g·L

-1

）、黄连组（38.4 g·L

-1

）、制吴茱萸组（5.88 g·L

-1

）、炒白芍组（18.68 g·L

-1

），每组65只，按临床饮片剂量折算成提取物剂量给药，给药后每组按药代动力学设定时间取血浆、肝、小肠和脑。采用超高效液相色谱-三重四极杆串联质谱法建立戊己丸中5个代表成分小檗碱（Ber）、巴马汀（Pal）、吴茱萸碱（Evo）、吴茱萸次碱（Rut）和芍药苷（Pae）在血浆、肝、小肠和脑中定量分析方法，血浆样品采用蛋白沉淀法、组织样品采用蛋白沉淀加液-液萃取法进行前处理，对各组给药前、给药后不同时间点血浆和组织样品进行代表成分的检测。采用非房室模型计算各成分药代动力学参数，并对各组药代参数进行比较。

结果

戊己丸组药代动力学结果显示，5种代表成分药-时曲线下面积（AUC

）大小排序如下：Ber和Pal为小肠

肝

血浆；Evo和Rut为肝

小肠

血浆；Pae为小肠

血浆，未在肝脏中检出；脑中除Ber外未检测到其他成分；与血浆及其他组织比较，戊己丸组肝脏中Ber、Pal、Evo、Rut的药峰浓度（

max

）均为最高且达峰时间（

max

）均为最低。在血浆中，与制吴茱萸组比较，戊己丸组中Evo和Rut的AUC

和

max

均增加，与炒白芍组比较，戊己丸组中Pae的

max

升高、

max

降低；在肝脏中，与各单味药组比较，戊己丸组中除Pae外各代表成分的

max

均升高，Pal的AUC

降低，Evo和Rut的AUC

升高；在小肠中，与各单味药组比较，戊己丸组中各代表成分的半衰期（

1/2

）升高、

max

降低，除Pal外各代表成分

max

降低，Ber、Pal的AUC

升高，Evo和Rut的AUC

则降低。

结论

小肠作为戊己丸的效应器官分布最多，其次为肝脏；戊己丸在配伍前后各代表成分的药代动力学参数发生了改变，更有利于戊己丸药效作用的发挥。

Abstract

Objective

To study the plasma pharmacokinetics and tissue distribution of five representative components in Wujiwan， and to illustrate the difference of metabolism and tissue distribution before and after compatibility.

Method

Healthy male SD rats were divided into four groups， including Wujiwan group（A group， 62.96 g·L

-1

）， Coptidis Rhizoma group（B group， 38.4 g·L

-1

）， processed Euodiae Fructus

group（C group， 5.88 g·L

-1

） and fried Paeoniae Radix Alba group（D group， 18.68 g·L

-1

）， with 65 rats in each group， and were administered the drugs according to the clinical dose of decoction pieces converted into the dose of the extracts. Then plasma， liver， small intestine and brain were taken at pharmacokinetic set time in each group after administration. Ultra-high performance liquid chromatography-triple quadrupole tandem mass spectrometry was developed for the quantitative analysis of five representative components［berberine（Ber）， palmatine（Pal）， evodiamine（Evo）， rutecarpine（Rut） and paeoniflorin（Pae）］ in Wujiwan， their concentrations in plasma， liver， small intestine and brain were detected at different time， plasma samples were processed by protein precipitation， and tissue samples were pretreated by protein precipitation plus liquid-liquid extraction. Non-atrioventricular model was used to calculate the pharmacokinetic parameters of each component， and the parameters of each group were compared.

Result

Pharmacokinetic results of A group showed that area under the curve（AUC

） of the five representative components were ranked as follows：Ber and Pal were small intestine

liver

blood， Evo and Rut were liver

small intestine

plasma， Pae was small intestine

plasma， which was not detected in the liver， no other components were detected in brain except for Ber. In comparison with plasma and other tissues， peak concentration（

max

） of Ber， Pal， Evo， and Rut were the highest and time to peak（

max

） were the lowest in the liver of A group. In plasma， the AUC

and

max

of Evo and Rut were increased in A group compared with C group，

max

of Pea was elevated and its

max

was decreased in A group compared with D group

In the liver， compared with B-D groups，

max

values of 5 representative components except Pae were elevated， AUC

of Pae was decreased and AUC

of Evo and Rut were increased in the A group. In the small intestine， half-life（

1/2

） of each representative components in A group was elevated and

max

was decreased， and

max

of each representative ingredient except Pal was decreased， AUC

values of Ber and Pal were increased， whereas the AUC

values of Evo and Rut were decreased.

Conclusion

The small intestine， as the effector organ， is the most distributed， followed by the liver. The pharmacokinetic parameters of the representative components in Wujiwan are changed before and after compatibility， which is more favorable to the exertion of its pharmacodynamic effects.

关键词

Keywords

references

王永炎，王忠 . 整体观视角对中医方剂配伍的研究［J］. 中国中药杂志， 2016 ， 41 （ 15 ）： 2749 - 2752 .

丁黎，刘瑞娟 . 中药药代动力学研究的思与行［J］. 世界科学技术-中医药现代化， 2017 ， 19 （ 7 ）： 1118 - 1131 .

巩仔鹏，林朝展，韩立炜 . 从国家自然科学基金资助项目浅析中药药代动力学研究现状［J］. 中国中药杂志， 2021 ， 46 （ 4 ）： 1010 - 1016 .

王娅杰，崔羲和，陈颖，等 . 戊己丸不同配伍方治疗肠易激综合征的比较［J］. 中国实验方剂学杂志， 2021 ， 27 （ 13 ）： 1 - 9 .

王娅杰，董宇，朱晓新 . 戊己丸提取物不同配伍方对豚鼠离体结肠运动影响的实验研究［J］. 中国中药杂志， 2007 ， 32 （ 20 ）： 2161 - 2165 .

黄鹤飞，强伟杰，杨庆，等 . 戊己丸对炎症后肠易激综合征大鼠脑肠肽的调控作用［J］. 中国实验动物学报， 2018 ， 26 （ 3 ）： 265 - 271 .

董宇，张英丰，杨庆，等 . 戊己丸提取物不同配伍的肠外翻吸收研究［J］. 中国药理学通报， 2010 ， 26 （ 10 ）： 1377 - 1382 .

王怡薇，王彦礼，李玉洁，等 . 戊己丸不同配伍对代表成分吸收及肝脏摄取的影响［J］. 中华中医药杂志， 2012 ， 27 （ 4 ）： 793 - 798 .

王怡薇，张英丰，李玉洁，等 . 戊己丸不同配伍对代表成分胆汁排泄的影响［J］. 中国中药杂志， 2011 ， 36 （ 23 ）： 3319 - 3326 .

ZHAO M Y ， ZHOU P ， YU J ， et al . The tissue distribution and excretion study of paeoniflorin-6'- O -benzene sulfonate（CP-25）in rats ［J］. Inflammopharmacology ， 2019 ， 27 （ 5 ）： 969 - 974 .

HU Z C ， LI M X ， YAO L ， et al . The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome：A network Meta-analysis ［J］. BMC Gastroenterol ， 2021 ， 21 （ 1 ）： 23 .

MISHIMA Y ， ISHIHARA S . Molecular mechanisms of microbiota-mediated pathology in irritable bowel syndrome ［J］. Int J Mol Sci ， 2020 ， 21 （ 22 ）： 8664 .

CRYAN J F ， O'RIORDAN K J ， COWAN C S M ， et al . The microbiota-gut-brain axis ［J］. Physiol Rev . 2019 ， 99 （ 4 ）： 1877 - 2013 .

MARTIN C R ， OSADCHIY V ， KALANI A ， et al . The brain-gut-microbiome axis ［J］. Cell Mol Gastroenterol Hepatol ， 2018 ， 6 （ 2 ）： 133 - 148 .

黄鹤飞，强伟杰，杨庆，等 . 戊己丸对炎症后肠易激综合征大鼠脑肠肽的调控作用［J］. 中国实验动物学报， 2018 ， 26 （ 3 ）： 265 - 271 .

王迎寒，周淑媛，王娅杰，等 . 戊己丸不同配伍方对炎症后肠易激综合征模型大鼠结肠运动及5-羟色胺含量的影响［J］. 世界华人消化杂志， 2013 ， 21 （ 13 ）： 1226 - 1233 .

CHEN Y ， XIAO S M ， GONG Z P ， et al . Wuji Wan formula ameliorates diarrhea and disordered colonic motility in post-inflammation irritable bowel syndrome rats by modulating the gut microbiota ［J］. Front Microbiol ， 2017 ， 8 ： 2307 .

郭雨轩，张淑涵，王安琪，等 . 基于UPLC-Q-TOF-MS/MS和网络药理学探讨戊己丸药效物质基础及疾病治疗潜能分析［J］. 中国中药杂志， 2022 ， 47 （ 24 ）： 6720 - 6729 .

CUI H M ， ZHANG Q Y ， WANG J L ， et al . In vitro studies of berberine metabolism and its effect of enzyme induction on HepG2 cells ［J］. J Ethnopharmacol ， 2014 ，158 Pt A：388- 396 .

CUI H M ， WANG J L ， ZHANG Q Y ， et al . In vivo and in vitro study on drug-drug interaction of lovastatin and berberine from pharmacokinetic and HepG2 cell metabolism studies ［J］. Molecules ， 2016 ， 21 （ 4 ）： 464 .

王旭，徐蓓蕾，吴迪，等 . 不同配伍比例的黄连-吴茱萸药对研究进展［J］. 中国实验方剂学杂志， 2020 ， 26 （ 3 ）： 21 - 30 .

董宇，张英风，杨庆，等 . 炒白芍提取物在大鼠肠外翻囊实验中的吸收及与P-gp相互作用研究［J］. 中国中药杂志， 2009 ， 34 （ 7 ）： 884 - 888 .

董宇，张英丰，杨庆，等 . 制吴茱萸提取物在肠外翻中的吸收研究及与P-gp的关系［J］. 世界科学技术—中医药现代化， 2008 ， 10 （ 2 ）： 63 - 68 .

张红，陈颖，巩仔鹏，等 . 戊己丸中活性成分在正常大鼠和肠易激综合征大鼠体内药代动力学行为的差异性分析［J］. 中国实验方剂学杂志， 2021 ， 27 （ 17 ）： 124 - 131 .

GONG Z P ， YANG Q ， WANG Y J ， et al . Pharmacokinetic differences of Wuji pill components in normal and chronic visceral hypersensitivity irritable bowel syndrome rats attributable to changes in tight junction and transporters ［J］. Front Pharmacol ， 2022 ， 13 ： 948678 .

Views

173

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Euodiae Fructus on Tissue Distribution of Active Components from Coptidis Rhizoma in Rats

Comparison of Pharmacokinetics and Tissue Distribution of Free Anthraquinones and Gallic Acid in Mice with Ulcerative Colitis Before and After Processing of Rhei Radix et Rhizoma Carbonisata

Explanation of Scientific Connotation of Euodiae Fructus Stir-fried with Coptidis Rhizoma Based on UPLC-Q-TOF/MS and Pattern Recognition Technology

Analysis of Zuojinwan Based on Ancient Literature

Related Author

LIANG Rui-feng

ZHANG Feng

LI Geng-sheng

SHI Li-fei

SUN Jing

QI Yunpeng

LI Siyuan

HU Yingbo

Related Institution

School of Life Sciences， Beijing University of Chinese Medicine

School of Pharmacy， Jiangxi University of Chinese Medicine

Beijing Increasepharm Co. Ltd.

Academy for Advanced Interdisciplinary Studies，School of Pharmaceutical Sciences， State Key Laboratory of Natural and Biomimetic Drugs，Peking University

Increasepharm （Tianjin） Institute Co. Ltd.

AI脑图

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰